Masahiro Iwasaku

Kyoto, 6028566, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 89 publications

Baseline neutrophil-to-lymphocyte ratio predicts survival time after the initiation of nintedanib in patients with interstitial lung disease.

Baseline neutrophil-to-lymphocyte ratio predicts survival time after the initiation of nintedanib in patients with interstitial lung disease.

Journal: BMC pulmonary medicine

Published: March 11, 2026

Efficacy and safety of nintedanib for older adults with idiopathic pulmonary fibrosis or progressive fibrosing interstitial lung disease: A multicenter retrospective study in Japan.

Efficacy and safety of nintedanib for older adults with idiopathic pulmonary fibrosis or progressive fibrosing interstitial lung disease: A multicenter retrospective study in Japan.

Journal: Respiratory investigation

Published: February 26, 2026

Identification of Hidden Cachexia Subgroup in PD-L1-High NSCLC: Comparative Analysis of the AWGC vs. Fearon Criteria.

Identification of Hidden Cachexia Subgroup in PD-L1-High NSCLC: Comparative Analysis of the AWGC vs. Fearon Criteria.

Journal: Journal of cachexia, sarcopenia and muscle

Published: November 24, 2025

Hydrostatic pressure from basal side promotes cancer proliferation, enhances migration, and alters cell polarity: A model of the effects of interstitial fluid pressure in tumor microenvironment.

Hydrostatic pressure from basal side promotes cancer proliferation, enhances migration, and alters cell polarity: A model of the effects of interstitial fluid pressure in tumor microenvironment.

Journal: Molecular biology of the cell

Published: November 19, 2025

Prevalence and molecular landscape of NRG1 fusions in Japanese solid tumors: a nationwide data analysis using the C-CAT database.

Prevalence and molecular landscape of NRG1 fusions in Japanese solid tumors: a nationwide data analysis using the C-CAT database.

Journal: Lung cancer (Amsterdam, Netherlands)

Published: November 05, 2025

Initial biomarker testing strategies and clinical outcomes in advanced non-small cell lung cancer.

Initial biomarker testing strategies and clinical outcomes in advanced non-small cell lung cancer.

Journal: iScience

Published: October 02, 2025

Prognostic factors in patients with interstitial lung disease treated with nintedanib: a multicenter retrospective study in Japan.

Prognostic factors in patients with interstitial lung disease treated with nintedanib: a multicenter retrospective study in Japan.

Journal: Scientific reports

Published: September 04, 2025

Gut microbiome-driven modulation of the tumor immune microenvironment optimizes dual checkpoint blockade in advanced non-small-cell lung cancer.

Gut microbiome-driven modulation of the tumor immune microenvironment optimizes dual checkpoint blockade in advanced non-small-cell lung cancer.

Journal: ESMO open

Published: May 27, 2025

Impact of mutant protein expression on clinical outcomes in patients with EGFR L858R-mutated non-small cell lung cancer.

Impact of mutant protein expression on clinical outcomes in patients with EGFR L858R-mutated non-small cell lung cancer.

Journal: Translational lung cancer research

Published: February 03, 2025

Clinical impact of cancer cachexia on the outcome of patients with non-small cell lung cancer with PD-L1 tumor proportion scores of ≥50% receiving pembrolizumab monotherapy versus immune checkpoint inhibitor with chemotherapy.

Clinical impact of cancer cachexia on the outcome of patients with non-small cell lung cancer with PD-L1 tumor proportion scores of ≥50% receiving pembrolizumab monotherapy versus immune checkpoint inhibitor with chemotherapy.

Journal: Oncoimmunology

Published: December 16, 2024

Patients' Trajectory With Lung Cancer From Treatment Initiation to End-Of-Life: A Retrospective Cohort Study Using Claims Data in Japan.

Patients' Trajectory With Lung Cancer From Treatment Initiation to End-Of-Life: A Retrospective Cohort Study Using Claims Data in Japan.

Journal: Cancer control : journal of the Moffitt Cancer Center

Published: November 29, 2024

A 5-year review of genomic medicine in breast cancer: insights from C-CAT data on 3776 Japanese patients.

A 5-year review of genomic medicine in breast cancer: insights from C-CAT data on 3776 Japanese patients.

Journal: Breast cancer (Tokyo, Japan)

Published: August 15, 2024

Showing 1-12 of 89

Last Updated: 09/26/2026